Active ingredientAvoralstatCat. No. P-A225-001CAS 918407-35-9Family · Pharmaceutical analytical standards
Avoralstat
An oral plasma kallikrein inhibitor studied in the 2010s to prevent attacks of hereditary angioedema; in the OPuS-2 study, whose results were announced in 2016, this formulation did not reduce attacks compared with placebo. This family brings together the active ingredient.
Did you know?By blocking kallikrein it cuts the production of bradykinin, the mediator that triggers the sudden swelling attacks typical of hereditary angioedema.
Go to the active ingredient →Active ingredientAvoralstatCat. No. P-A225-001CAS 918407-35-9No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.